ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

30,874Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 98

$1.92M Total Retail Price of All Prescriptions

Rank: 4 out of 98

545 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 545 patients filled at least one prescription for a schedule two drug, compared to an average of 10%.

Schedule Three
Controlled Substances

9% of this provider’s 545 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

2% of this provider’s 24,952 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $48 among peers.

Prescriptions per Patient

57 is the average number of prescriptions (including refills) per patient, compared to an average of 34.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
FUROSEMIDE 1,418 1,275 1 4
SIMVASTATIN 1,178 1,074 2 2
WARFARIN SODIUM 1,079 871 3 1
METOPROLOL TARTRATE 1,042 931 4 8
TRAZODONE HCL 961 832 5 9
LISINOPRIL 865 716 6 3
AMLODIPINE BESYLATE 740 659 7 7
CITALOPRAM HBR 708 558 8 10
LEVOTHYROXINE SODIUM 693 594 9 5
MIRTAZAPINE 660 560 10 11
OLANZAPINE 628 468 11 24
RISPERIDONE 585 497 12 27
GABAPENTIN 543 434 13 13
DIVALPROEX SODIUM 541 435 14 22
OMEPRAZOLE 519 364 15 6
LEVETIRACETAM 491 298 16 38
POTASSIUM CHLORIDE 487 409 17 21
QUETIAPINE FUMARATE 480 382 18 23
NOVOLIN N 388 323 10 19 85
SERTRALINE HCL 365 330 20 19
NOVOLIN R 326 288 21 79
METFORMIN HCL 324 234 22 15
PREDNISONE 286 273 23 31
DONEPEZIL HCL 277 273 24 12
ATENOLOL 273 250 25 14
BACLOFEN 263 127 26 59
NAMENDA 260 238 27 18
RANITIDINE HCL 257 200 28 35
GLIPIZIDE 243 237 29 37
METOCLOPRAMIDE HCL 232 162 30 102
PANTOPRAZOLE SODIUM 215 180 31 42
METOPROLOL SUCCINATE 215 177 31 16
LACTULOSE 210 133 33 62
CARBIDOPA-LEVODOPA 209 206 34 44
TRAMADOL HCL 203 159 35 26
PROPRANOLOL HCL 197 180 36 105
BENZTROPINE MESYLATE 196 138 R 37 89
LANTUS 191 155 38 28
TRICOR 187 114 39 171
ABILIFY 185 140 40 66
POLYETHYLENE GLYCOL 3350 179 149 41 33
GLYBURIDE 177 154 R 42 70
ALLOPURINOL 176 173 43 43
FLUOXETINE HCL 170 121 44 48
PAROXETINE HCL 164 148 45 73
TAMSULOSIN HCL 155 143 46 25
CLOZAPINE 154 84 47 55
SEROQUEL 152 129 48 52
OXYBUTYNIN CHLORIDE 146 119 49 166
CYMBALTA 143 116 50 47
HYDROCODONE-ACETAMINOPHEN 140 119 S3 51 39
CLOPIDOGREL 139 131 52 50
LAMOTRIGINE 138 101 53 87
IBUPROFEN 135 116 54 74
IPRATROPIUM-ALBUTEROL 135 106 54 45
NYSTATIN 130 122 56 56
CARVEDILOL 127 122 57 72
ATORVASTATIN CALCIUM 126 99 58 20
LEVOFLOXACIN 123 109 59 63
ESCITALOPRAM OXALATE 112 81 60 60
HYDROCHLOROTHIAZIDE 110 81 61 17
TERAZOSIN HCL 108 94 62 94
NOVOLOG 106 85 63 54
ADVAIR DISKUS 106 106 63 32
PLAVIX 105 99 65 76
CLOTRIMAZOLE-BETAMETHASONE 103 97 66 115
ROPINIROLE HCL 101 88 67 91
SSD 97 83 68 198
SPIRONOLACTONE 95 59 69 71
TRIAMCINOLONE ACETONIDE 94 85 70 93
HUMULIN N 93 76 71 140
DIGOXIN 91 91 72 40
LIDODERM 90 84 73 29
LATANOPROST 90 90 73 67
FINASTERIDE 90 78 73 49
PERMETHRIN 84 84 76 193
DILANTIN 83 39 77 132
DILTIAZEM 24HR CD 83 83 77 83
HYDROXYZINE HCL 81 66 R 79 207
FAMOTIDINE 79 45 80 80
ISOSORBIDE MONONITRATE ER 78 72 81 36
FLUTICASONE PROPIONATE 77 53 82 53
DOXYCYCLINE HYCLATE 76 68 83 168
SULFAMETHOXAZOLE-TRIMETHOPRIM 76 27 83 114
SPIRIVA 76 68 83 46
VENLAFAXINE HCL ER 75 53 86 65
PHENYTOIN SODIUM EXTENDED 73 36 87 101
SANTYL 73 36 87 156
ALBUTEROL SULFATE 70 32 89 106
NIFEDIPINE ER 69 40 90 68
NITROGLYCERIN PATCH 67 67 91 113
VENLAFAXINE HCL 65 29 92 116
METOLAZONE 63 63 93 184
DOXAZOSIN MESYLATE 63 53 93 98
VALPROIC ACID 63 26 93 140
BRIMONIDINE TARTRATE 63 61 93 95
CLONIDINE HCL 62 38 97 108
HUMULIN R 61 52 98 271
DIVALPROEX SODIUM ER 61 37 98 84
HALOPERIDOL 61 46 98 112
ALENDRONATE SODIUM 60 49 101 30
TOPIRAMATE 60 15 101 148
GENERLAC 59 59 103 82
CARBAMAZEPINE 59 22 103 159
CEPHALEXIN 57 49 105 92
GLUCAGEN 57 45 105 165
HYDRALAZINE HCL 57 47 105 75
PROCHLORPERAZINE MALEATE 57 25 105 277
RAMIPRIL 56 53 109 109
CLONIDINE 56 50 109 222
SODIUM CHLORIDE 55 37 111 286
TIMOLOL MALEATE 55 55 111 118
OXCARBAZEPINE 55 40 111 179
LANSOPRAZOLE 54 54 114 220
AGGRENOX 54 45 114 103
TRIAMTERENE-HCTZ 53 40 116 111
LABETALOL HCL 52 36 117 127
AMOXICILLIN 51 49 118 298
MUPIROCIN 51 21 118 123
SINGULAIR 50 48 120 117
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.